We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Renal Cell Carcinoma

Journal Scan / Research · August 16, 2022

Association of Weight Loss With Cabozantinib Use in Patients With mRCC

Journal of Cachexia, Sarcopenia and Muscle


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Cachexia, Sarcopenia and Muscle
Weight and skeletal muscle loss with cabozantinib in metastatic renal cell carcinoma
J Cachexia Sarcopenia Muscle 2022 Jul 28;[EPub Ahead of Print], E Colomba, C Alves Costa Silva, G Le Teuff, J Elmawieh, D Afonso, A Benchimol-Zouari, A Guida, L Derosa, R Flippot, B Raynard, B Escudier, F Bidault, L Albiges

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading